1 – 10 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
- Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
- A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers
- HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures
- Societal challenges of precision medicine : Bringing order to chaos
- Somatic mutations reveal asymmetric cellular dynamics in the early human embryo
- 2016
- Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
- The advantage of laser-capture microdissection over whole tissue analysis in proteomic profiling studies
- 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
- Prognostic significance of nuclear expression of UMP-CMP kinase in triple negative breast cancer patients
- Targeted MS Assay Predicting Tamoxifen Resistance in Estrogen-Receptor-Positive Breast Cancer Tissues and Sera